Effects of Regular Brisk Walking in Chronic Stroke Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT01570920
First received: March 30, 2010
Last updated: April 2, 2012
Last verified: April 2012
  Purpose

Chronic stroke patients (>6 months) fulfilling including criteria were trained during 3 months. The physical training program was based on walking.


Condition Intervention
Stroke
Behavioral: physical training

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Effects of Regular Brisk Walking in Chronic Stroke Patients

Resource links provided by NLM:


Further study details as provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Primary Outcome Measures:
  • ACTIVLIM-Stroke (Activity limitations measures) [ Time Frame: 7 months ] [ Designated as safety issue: Yes ]
    mainly self-reported outcomes measures


Secondary Outcome Measures:
  • Stroke Impairment [ Time Frame: 7 months ] [ Designated as safety issue: Yes ]
    Stroke related impairment are assessed with specific outcomes measures (SIAS, BBS, ...).

  • Walking ability [ Time Frame: 7 months ] [ Designated as safety issue: Yes ]
    Walking ability is assessed throuht walking speed and walking endurance


Enrollment: 34
Study Start Date: September 2009
Study Completion Date: March 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: walking
a cohort of stroke patients trained during 3 month, based on walking
Behavioral: physical training
walking many times a week

Detailed Description:

Participants had been evaluated 4 times during a long follow-up period of 7 months. Activity limitations were assessed at baseline (enrollment time point), 1 month, 4 months and 7 months later.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stroke onset > or = 6 months
  • Able to walk without human assistance (may use walking aid)
  • Sign informed consent form
  • Approval from physician for participation in study
  • Live in Belgium or in Benin

Exclusion Criteria:

  • cardiac history of active unstable angina, recent (less than 3 months) myocardial infarction, or congestive heart failure
  • orthopedic, circulatory, or chronic pain conditions restricting exercise;
  • dementia;
  • severe receptive or global aphasia with inability to follow 2-step commands;
  • co-morbid non-stroke neurological disorder that impairs mobility (e.g. MS or Parkinson's);
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01570920

Locations
Belgium
Institut of Neuroscience (IoNS) / UCL, 5375
Brussels, Belgium, 1200
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: Jean-Louis Thonnard, PhD Université catholique de Louvain - Belgium
  More Information

No publications provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier: NCT01570920     History of Changes
Other Study ID Numbers: 2008/04JUIL/193
Study First Received: March 30, 2010
Last Updated: April 2, 2012
Health Authority: Belgium: Institutional Review Board

Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:
Activity limitations
restriction of participation
chronic stroke survival
physical activity
walking

Additional relevant MeSH terms:
Stroke
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on April 17, 2014